FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281567558> ?p ?o ?g. }

• W4281567558 endingPage "1841" @default.
• W4281567558 startingPage "1831" @default.
• W4281567558 abstract "IntroductionPatients with IgA nephropathy (IgAN) and persistent proteinuria are at risk of progression to kidney failure. Atacicept is a novel B-cell–targeted immunomodulator, shown to reduce immunoglobulin levels in patients with autoimmune diseases.MethodsJANUS (NCT02808429) was a phase II study that assessed the safety, pharmacodynamic effects, and efficacy of atacicept in patients with IgAN and proteinuria ≥1 g/d or 0.75 mg/mg on 24-hour UPCR despite maximal standard of care therapy.ResultsA total of 16 patients were randomized 1:1:1 to placebo (n = 5), atacicept 25 mg (n = 6), or atacicept 75 mg (n = 5) once weekly using subcutaneous injection. Twelve (75%) completed ≥48 weeks of treatment; 8 (50%) completed 72 weeks of treatment and the 24-week safety follow-up period. Fourteen patients reported treatment-emergent adverse events (TEAEs). Most TEAEs were mild or moderate in severity. Three patients (placebo n = 1; atacicept 25 mg n = 2) reported serious TEAEs, none of which were treatment related. Dose-dependent reductions in IgA, IgG, IgM, and galactose-deficient (Gd)-IgA1 with atacicept at week 24 were maintained to week 72. Early reduction in proteinuria was observed at week 24 with atacicept. Renal function progressively declined with placebo but remained stable under exposure to atacicept.ConclusionAtacicept has an acceptable safety profile in patients with IgAN and is effective at reducing the levels of pathogenic factor Gd-IgA1, with potential improvements in proteinuria and renal function." @default.
• W4281567558 created "2022-05-27" @default.
• W4281567558 creator A5000748568 @default.
• W4281567558 creator A5023188102 @default.
• W4281567558 creator A5030198175 @default.
• W4281567558 creator A5045290398 @default.
• W4281567558 creator A5052697817 @default.
• W4281567558 creator A5055078486 @default.
• W4281567558 creator A5057786205 @default.
• W4281567558 creator A5076815130 @default.
• W4281567558 creator A5090030145 @default.
• W4281567558 date "2022-08-01" @default.
• W4281567558 modified "2023-09-30" @default.
• W4281567558 title "Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria" @default.
• W4281567558 cites W1625166229 @default.
• W4281567558 cites W164979229 @default.
• W4281567558 cites W1974000182 @default.
• W4281567558 cites W2004730097 @default.
• W4281567558 cites W2024266233 @default.
• W4281567558 cites W2032354231 @default.
• W4281567558 cites W2033296455 @default.
• W4281567558 cites W2053949930 @default.
• W4281567558 cites W2133473614 @default.
• W4281567558 cites W2135143233 @default.
• W4281567558 cites W2138161657 @default.
• W4281567558 cites W2151492920 @default.
• W4281567558 cites W2154831555 @default.
• W4281567558 cites W2212745154 @default.
• W4281567558 cites W2557141247 @default.
• W4281567558 cites W2586394131 @default.
• W4281567558 cites W2625366743 @default.
• W4281567558 cites W2897379207 @default.
• W4281567558 cites W2898030084 @default.
• W4281567558 cites W2911011964 @default.
• W4281567558 cites W2924734038 @default.
• W4281567558 cites W2966305176 @default.
• W4281567558 cites W3007483088 @default.
• W4281567558 cites W3080629152 @default.
• W4281567558 cites W3195096042 @default.
• W4281567558 cites W4239867451 @default.
• W4281567558 cites W4247172809 @default.
• W4281567558 doi "https://doi.org/10.1016/j.ekir.2022.05.017" @default.
• W4281567558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35967104" @default.
• W4281567558 hasPublicationYear "2022" @default.
• W4281567558 type Work @default.
• W4281567558 citedByCount "18" @default.
• W4281567558 countsByYear W42815675582022 @default.
• W4281567558 countsByYear W42815675582023 @default.
• W4281567558 crossrefType "journal-article" @default.
• W4281567558 hasAuthorship W4281567558A5000748568 @default.
• W4281567558 hasAuthorship W4281567558A5023188102 @default.
• W4281567558 hasAuthorship W4281567558A5030198175 @default.
• W4281567558 hasAuthorship W4281567558A5045290398 @default.
• W4281567558 hasAuthorship W4281567558A5052697817 @default.
• W4281567558 hasAuthorship W4281567558A5055078486 @default.
• W4281567558 hasAuthorship W4281567558A5057786205 @default.
• W4281567558 hasAuthorship W4281567558A5076815130 @default.
• W4281567558 hasAuthorship W4281567558A5090030145 @default.
• W4281567558 hasBestOaLocation W42815675581 @default.
• W4281567558 hasConcept C126322002 @default.
• W4281567558 hasConcept C134018914 @default.
• W4281567558 hasConcept C142724271 @default.
• W4281567558 hasConcept C168563851 @default.
• W4281567558 hasConcept C197934379 @default.
• W4281567558 hasConcept C203014093 @default.
• W4281567558 hasConcept C204787440 @default.
• W4281567558 hasConcept C27081682 @default.
• W4281567558 hasConcept C2779561371 @default.
• W4281567558 hasConcept C2780091579 @default.
• W4281567558 hasConcept C2781184683 @default.
• W4281567558 hasConcept C555293320 @default.
• W4281567558 hasConcept C71924100 @default.
• W4281567558 hasConcept C90924648 @default.
• W4281567558 hasConceptScore W4281567558C126322002 @default.
• W4281567558 hasConceptScore W4281567558C134018914 @default.
• W4281567558 hasConceptScore W4281567558C142724271 @default.
• W4281567558 hasConceptScore W4281567558C168563851 @default.
• W4281567558 hasConceptScore W4281567558C197934379 @default.
• W4281567558 hasConceptScore W4281567558C203014093 @default.
• W4281567558 hasConceptScore W4281567558C204787440 @default.
• W4281567558 hasConceptScore W4281567558C27081682 @default.
• W4281567558 hasConceptScore W4281567558C2779561371 @default.
• W4281567558 hasConceptScore W4281567558C2780091579 @default.
• W4281567558 hasConceptScore W4281567558C2781184683 @default.
• W4281567558 hasConceptScore W4281567558C555293320 @default.
• W4281567558 hasConceptScore W4281567558C71924100 @default.
• W4281567558 hasConceptScore W4281567558C90924648 @default.
• W4281567558 hasIssue "8" @default.
• W4281567558 hasLocation W42815675581 @default.
• W4281567558 hasLocation W42815675582 @default.
• W4281567558 hasLocation W42815675583 @default.
• W4281567558 hasOpenAccess W4281567558 @default.
• W4281567558 hasPrimaryLocation W42815675581 @default.
• W4281567558 hasRelatedWork W1977915442 @default.
• W4281567558 hasRelatedWork W2064879719 @default.
• W4281567558 hasRelatedWork W2085830368 @default.
• W4281567558 hasRelatedWork W2323324971 @default.
• W4281567558 hasRelatedWork W3159250744 @default.

• next